What autoimmune disease is most commonly associated with type 1 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Autoimmune Thyroid Disease is the Most Common Autoimmune Disorder Associated with Type 1 Diabetes

Autoimmune thyroid disease (AITD), particularly Hashimoto's thyroiditis, is the most common autoimmune disorder associated with type 1 diabetes mellitus. 1

Prevalence and Association

  • According to the American Diabetes Association guidelines, approximately 10.5% of patients with type 1 diabetes develop autoimmune thyroid disorders 1
  • The prevalence of thyroid autoantibodies in children with type 1 diabetes at disease onset is about 20% and is particularly common in females 2
  • Patients with type 1 diabetes are prone to other autoimmune disorders, with AITD being the most prevalent endocrinopathy among diabetic patients 3, 4

Types of Autoimmune Thyroid Disease in T1DM

  1. Hashimoto's thyroiditis (most common)

    • Characterized by the presence of anti-thyroid peroxidase (anti-TPO) antibodies
    • May cause weight gain, hyperlipidemia, goiter, and affect diabetes control 4
    • Found in 9.5% of patients with type 1 diabetes in recent studies 5
  2. Graves' disease

    • Characterized by TSH receptor antibodies (TSI)
    • May induce weight loss, atrial fibrillation, and heat intolerance 4
    • Found in 3.1% of patients with type 1 diabetes 5

Other Common Autoimmune Comorbidities

While AITD is the most common, other autoimmune conditions associated with type 1 diabetes include:

  • Celiac disease: Second most common (4-9% prevalence) 4, 1
  • Autoimmune gastritis/pernicious anemia: 5-10% prevalence 4
  • Addison's disease: 0.5% prevalence 4
  • Vitiligo: 2-10% prevalence 4

Screening Recommendations

The American Diabetes Association recommends:

  • Testing for both anti-thyroid peroxidase and anti-thyroglobulin antibodies in patients with type 1 diabetes soon after diagnosis 6
  • Measurement of anti-thyroid antibodies and TSH at type 1 diabetes onset and yearly intervals after age 12 2
  • Patients with anti-thyroid antibodies are 18 times more likely to develop thyroid disease than those without 2

Clinical Implications

  • The presence of AITD in patients with type 1 diabetes may negatively affect metabolic management 7
  • Hypothyroidism in patients with type 1 diabetes can deteriorate glycemic control and lead to increased rates of hypoglycemia 3
  • Female sex and duration of AITD more than five years are associated with increased odds of associated autoimmune disorders 5

Pathophysiological Connection

Both type 1 diabetes and AITD share common genetic susceptibility factors:

  • Strong HLA associations, particularly with DQA and DQB genes 1
  • Similar autoimmune mechanisms involving T-cell mediated destruction of target organs

Early detection of thyroid dysfunction in patients with type 1 diabetes is crucial for preventing complications and optimizing diabetes management.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Type 1 diabetes and autoimmunity.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2014

Guideline

Thyroid Autoantibodies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.